2022
DOI: 10.1080/10715762.2022.2096450
|View full text |Cite
|
Sign up to set email alerts
|

Graphene oxide nanoflakes prevent reperfusion injury of Langendorff isolated rat heart providing antioxidative activity in situ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 70 publications
0
2
0
Order By: Relevance
“…In the cited study, GO and rGO (proportionally to a reduction degree) increased the cellular ROS content and lowered the mitochondrial membrane potential, suggesting the mitochondrial origin of at least a part of the ROS level increase that was observed. Recently, the cardioprotective effects of the 10–15-layer GO and oxidized (C/O ratio of 2.5–2.6) with a flake size between 0.1 and 200 μm were reported by Voitko et al 62 In their data, the post-ischemic CFM significantly improved in the GO-pretreated group (a 32% increase in comparison with the control). The authors proposed that the protective effect could be mediated through an ROS scavenging mechanism and demonstrated its chemical origin.…”
Section: Resultsmentioning
confidence: 89%
See 1 more Smart Citation
“…In the cited study, GO and rGO (proportionally to a reduction degree) increased the cellular ROS content and lowered the mitochondrial membrane potential, suggesting the mitochondrial origin of at least a part of the ROS level increase that was observed. Recently, the cardioprotective effects of the 10–15-layer GO and oxidized (C/O ratio of 2.5–2.6) with a flake size between 0.1 and 200 μm were reported by Voitko et al 62 In their data, the post-ischemic CFM significantly improved in the GO-pretreated group (a 32% increase in comparison with the control). The authors proposed that the protective effect could be mediated through an ROS scavenging mechanism and demonstrated its chemical origin.…”
Section: Resultsmentioning
confidence: 89%
“…In this study, to the best of our knowledge, the BSA-stabilized isotonic aqueous GO dispersions were intentionally used for the first time in the direct perfusion of the mammalian heart. Nonetheless, GO pretreatment was used in ischemia-reperfusion study protocol, 62 which led to an improvement in the coronary flow and reduction of the heart damage through free-radical scavenging mechanisms.…”
Section: Resultsmentioning
confidence: 99%